Protective Effects of GLP-1 on Glomerular Endothelium and Its Inhibition by PKCβ Activation in Diabetes
Article Information
vol. 61 no. 11 2967-2979
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 23, 2011
- Accepted May 12, 2012
- Published in print October 23, 2012.
- Published online ahead of print July 23, 2012.
Article Versions
- Previous version (July 23, 2012 - 07:00).
- Previous version (August 3, 2012 - 08:19).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
Author Information
- Akira Mima1,
- Junko Hiraoka-Yamomoto1,
- Qian Li1,
- Munehiro Kitada1,
- Chenzhong Li1,
- Pedro Geraldes2,
- Motonobu Matsumoto1,
- Koji Mizutani1,
- Kyoungmin Park1,
- Christopher Cahill1,
- Shin-Ichi Nishikawa3,
- Christian Rask-Madsen1 and
- George L. King1⇓
- 1Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts
- 2Department of Medicine, University of Sherbrooke, Sherbrooke, Quebec, Canada
- 3Laboratory for Stem Cell Biology, RIKEN Center for Developmental Biology, Kobe, Japan
- Corresponding author: George L. King, george.king{at}joslin.harvard.edu.
Statistics from Altmetric.com
Article usage
In this Issue
November 2012, 61(11)
Protective Effects of GLP-1 on Glomerular Endothelium and Its Inhibition by PKCβ Activation in Diabetes
